(Q28277784)

English

Feasibility, safety, and efficacy of the combination of D-serine and computerized cognitive retraining in schizophrenia: an international collaborative pilot study.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23093223%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Feasibility, safety, and efficacy of the combination of D-serine and computerized cognitive retraining in schizophrenia: an international collaborative pilot study (English)

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23093223%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Rajiv Radhakrishnan

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23093223%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

author name string

Deepak C D'Souza

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23093223%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Edward Perry

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23093223%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Savita Bhakta

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23093223%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Nagendra M Singh

5

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23093223%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Richa Yadav

6

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23093223%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Danielle Abi-Saab

7

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23093223%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Brian Pittman

8

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23093223%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Santosh K Chaturvedi

9

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23093223%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Mahendra P Sharma

10

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23093223%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Morris Bell

11

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23093223%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Chittaranjan Andrade

12

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23093223%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

language of work or name

0 references

publication date

24 October 2012

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23093223%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Neuropsychopharmacology

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23093223%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

38

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23093223%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23093223%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

492-503

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23093223%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

A meta-analysis of cognitive remediation in schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547200

20 March 2017

Cognitive training for supported employment: 2-3 year outcomes of a randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547200

20 March 2017

NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547200

20 March 2017

A rating scale for drug-induced akathisia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547200

20 March 2017

Cognitive Training for Supported Employment: 2-3 Year Outcomes of a Randomized Controlled Trial

1 reference

https://api.crossref.org/works/10.1038/NPP.2012.208

22 April 2017

Glycine transporter inhibitor attenuates the psychotomimetic effects of ketamine in healthy males: preliminary evidence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547200

29 September 2017

Negative symptoms of schizophrenia as primary target of cognitive behavioral therapy: results of the randomized clinical TONES study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547200

29 September 2017

Thinking about the future cognitive remediation therapy--what works and could we do better?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547200

29 September 2017

High dose D-serine in the treatment of schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547200

29 September 2017

Review on vocational predictors: a systematic review of predictors of vocational outcomes among individuals with schizophrenia: an update since 1998.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547200

29 September 2017

Group 5 metabotropic glutamate receptors: role in modulating cortical activity and relevance to cognition

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547200

29 September 2017

Report from the working group conference on multisite trial design for cognitive remediation in schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547200

29 September 2017

Treating the cognitive deficits of schizophrenia with alpha4beta2 neuronal nicotinic receptor agonists

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547200

29 September 2017

Activity-dependent synaptic plasticity of NMDA receptors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547200

29 September 2017

Glycine transport inhibitors for the treatment of schizophrenia: symptom and disease modification

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547200

29 September 2017

Predictors of change in life skills in schizophrenia after cognitive remediation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547200

29 September 2017

A randomized controlled trial of cognitive remediation in schizophrenia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547200

29 September 2017

Attention shaping: a reward-based learning method to enhance skills training outcomes in schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547200

29 September 2017

Recent advances in the development of novel pharmacological agents for the treatment of cognitive impairments in schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547200

29 September 2017

Efficacy and safety of donepezil in patients with schizophrenia or schizoaffective disorder: significant placebo/practice effects in a 12-week, randomized, double-blind, placebo-controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547200

29 September 2017

Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547200

29 September 2017

Inhibition of system A-mediated glycine transport in cortical synaptosomes by therapeutic concentrations of clozapine: implications for mechanisms of action

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547200

29 September 2017

The NMDA receptor glycine modulatory site: a therapeutic target for improving cognition and reducing negative symptoms in schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547200

29 September 2017

Half a century of antipsychotics and still a central role for dopamine D2 receptors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547200

29 September 2017

UCSD Performance-Based Skills Assessment: development of a new measure of everyday functioning for severely mentally ill adults

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547200

29 September 2017

Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547200

29 September 2017

Discovery of 4-(5-methyloxazolo[4,5-b]pyridin-2-yl)-1,4-diazabicyclo[3.2.2]nonane (CP-810,123), a novel alpha 7 nicotinic acetylcholine receptor agonist for the treatment of cognitive disorders in schizophrenia: synthesis, SAR development, and in vi

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547200

2 June 2018

AC-260584, an orally bioavailable M(1) muscarinic receptor allosteric agonist, improves cognitive performance in an animal model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547200

2 June 2018

A rating scale for extrapyramidal side effects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3547200

2 June 2018

Dopamine D1 receptor mechanisms in the cognitive performance of young adult and aged monkeys.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2012.208

21 January 2018

Attention training in schizophrenia: differing responses to similar tasks.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2012.208

21 January 2018

The effectiveness of computer-assisted cognitive rehabilitation for persons with traumatic brain injury.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2012.208

21 January 2018

A randomized, controlled trial of computer-assisted cognitive remediation for schizophrenia.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2012.208

21 January 2018

Differential effect of carbamazepine and oxcarbazepine on excitatory synaptic transmission in rat hippocampus

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2012.208

21 January 2018

Neurocognitive deficit in schizophrenia: a quantitative review of the evidence.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2012.208

21 January 2018

Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2012.208

21 January 2018

Lamotrigine inhibits postsynaptic AMPA receptor and glutamate release in the dentate gyrus

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2012.208

21 January 2018

Differential effects of atypical and typical antipsychotic drugs on N-methyl-D-aspartate- and electrically evoked responses in the pyramidal cells of the rat medial prefrontal cortex

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2012.208

21 January 2018

Medication management ability assessment: results from a performance-based measure in older outpatients with schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2012.208

21 January 2018

Social skills performance assessment among older patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2012.208

21 January 2018

Three year follow-up study of an integrated supported employment for individuals with severe mental illness.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2012.208

21 January 2018

Cognitive remediation therapy needs funding.

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2012.208

21 January 2018

Endogenous D-serine contributes to NMDA-receptor-mediated light-evoked responses in the vertebrate retina

1 reference

https://pubmed.ncbi.nlm.nih.gov/23093223

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Quality of Life Scale: an instrument for rating the schizophrenic deficit syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/23093223

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Microprocessor-based assessment of attention deficit disorders (ADD)

1 reference

https://pubmed.ncbi.nlm.nih.gov/23093223

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/23093223

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Positive and Negative Syndrome Scale (PANSS): rationale and standardisation

1 reference

https://pubmed.ncbi.nlm.nih.gov/23093223

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A depression rating scale for schizophrenics

1 reference

https://pubmed.ncbi.nlm.nih.gov/23093223

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Defining a cognitive function decrement in schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/23093223

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/NPP.2012.208

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23093223%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23093223%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23093223%20AND%20SRC:MED&resulttype=core&format=json

16 February 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28277784&oldid=2175203400"